AlphaYouKR
Insider selling
Kristian Reich sold $2.9M of MoonLake Immunotherapeutics (MLTX) stock
Kristian Reich, Chief Scientific Officer of MoonLake Immunotherapeutics (MLTX), sold 150,000 shares of MLTX stock worth $2.9M, per an SEC Form 4 filed Jun 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 15, 2026, 2 days before it was made public.
MLTX has moved -34.6% since the trade date, from $19.19 to $12.55 (Sep 21, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 2 days
- Price since
- -34.6%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More MLTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.